Skip to content
  • KOSPI 2726.25 +14.11 +0.52%
  • KOSDAQ 866.58 -3.57 -0.41%
  • KOSPI200 370.91 +2.08 +0.56%
  • USD/KRW 1368.6 +1.6 +0.12%
  • JPY100/KRW 878.97 -0.44 -0.05%
  • EUR/KRW 1474.8 +0.76 +0.05%
  • CNH/KRW 189.32 +0.04 +0.02%
View Market Snapshot
Bio & Pharma

Seegene's COVID-19 diagnostic product wins Product of the Year Award

The S.Korean diagnostic kit maker has developed Allplex SARS-CoV-2 Assay which detects 4 different target genes

By Dec 16, 2022 (Gmt+09:00)

1 Min read

Seegene's COVID-19 diagnostic product wins Product of the Year Award 

Seegene Inc. said on Friday that its COVID-19 diagnostic product Allplex SARS-CoV-2 Assay received the Product of the Year Award at the BioSpectrum Asia Excellence Awards on Dec 2.

BioSpectrum Asia is a media platform and market research firm that covers the pharmaceutical and biotech industries in the region.

 "We will contribute to the healthy life of mankind by strengthening R&D to enable faster and more accurate diagnosis of infectious diseases and genetic diseases, and widening the range of molecular diagnostics by producing excellent products," said Seegene CEO Chun Jong-Yoon.

"As a global leader in molecular diagnostics, we will continue to monitor and respond to future pandemics," he added.

In addition, Lunit, a Seoul-based medical AI company, received the Startup of the Year award.

Write to Jeong Min Nam at peux@hankyung.com
More to Read
Comment 0
0/300